The G1057D polymorphism of IRS-2 gene and its relationship with obesity in conferring susceptibility to type 2 diabetes in Asian Indians

International Journal of Obesity

Volumn 31, Issue 1, 2007, Pages 97-102

  Bodhini, D ^a   Radha, V ^a,e   Deepa, R ^a   Ghosh, S ^b   Majumder, P P ^b   Rao, M R S ^c,d   Mohan, V ^a  

^a MADRAS DIABETES RESEARCH FOUNDATION   (India)

^b INDIAN STATISTICAL INSTITUTE   (India)

^c INDIAN INSTITUTE OF SCIENCE   (India)

^d JAWAHARLAL NEHRU CENTRE FOR ADVANCED SCIENTIFIC RESEARCH   (India)

^e Dr Mohan's Diabetes Specialities Centre   (India)

Author keywords

Asian Indians; G1057D polymorphism; Insulin signalling; IRS 2 gene; Type 2 diabetes

Indexed keywords

INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 2;

ADULT; ARTICLE; BODY MASS; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; GLUCOSE TOLERANCE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT;

DIABETES MELLITUS, TYPE 2; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INDIA; INSULIN; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; OBESITY; PHOSPHOPROTEINS; POLYMORPHISM, GENETIC; RISK FACTORS; RURAL HEALTH; SIGNAL TRANSDUCTION;

EID: 33845772965     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/sj.ijo.0803356     Document Type: Article

References (32)

1. Sun XJ, Wang L-M, Zhang Y, Yenush L, Myers Jr MG, Glasheen E et al. Role of IRS-2 in insulin and cytokine signalling. Nature 1995; 377: 173-177.
2. Withers DJ, Gutierrez JS, Towery H, Burks DJ, Ren JM, Previs S et al. Disruption of IRS-2 causes type 2 diabetes in mice. Nature 1998; 391: 900-904.
3. Withers DJ, Burks DJ, Towery HH, Altamuro SL, Flint CL, White MF. IRS-2 coordinates Igf-1 receptor-mediated beta-cell development and peripheral insulin signalling. Nat Genet 1999; 23: 32-40.
4. Bernal D, Almind K, Yenush L, Ayoub M, Zhang Y, Rosshani L et al. Insulin receptor substrate-2 amino acid polymorphisms are not associated with random type 2 diabetes among Caucasians. Diabetes 1998; 47: 976-979.
5. Almind K, Frederiksen SK, Bernal D, Hansen T, Ambye L, Urhammer S et al. Search for variants of the gene-promoter and the potential phosphotyrosine encoding sequence of the insulin receptor substrate-2 gene: evaluation of their relation with alterations in insulin secretion and insulin sensitivity. Diabetologia 1999; 42: 1244-1249.
6. Wang H, Rissanen J, Miettinen R, Karkkainen P, Kekalainen P, Kuusisto J et al. New amino acid substitutions in the IRS-2 gene in Finnish and Chinese subjects with late-onset type 2 diabetes. Diabetes 2001; 50: 1949-1951.
7. Fritsche A, Madaus A, Renn W, Tschritter O, Teigeler A, Weisser M et al. The prevalent Gly1057Asp polymorphism in the insulin receptor substrate-2 gene is not associated with impaired insulin secretion. J Clin Endocrinol Metab 2001; 86: 4822-4825.
8. Mammarella S, Romano F, Di Valerio A, Creati B, Esposito DL, Palmirotta R et al. Interaction between the G1057D variant of IRS-2 and overweight in the pathogenesis of type 2 diabetes. Hum Mol Genet 2000; 9: 2517-2521.
9. Stefan N, Kovacs P, Stumvoll M, Hanson RL, Lehn-Stefan A, Permana PA et al. Metabolic effects of the Gly1057Asp polymorphism in IRS-2 and interactions with obesity. Diabetes 2003; 52: 1544-1550.
10. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabet Care 2004; 27: 1047-1053.
11. Mohan V, Sharp PS, Cloke HR, Burrin JM, Schumer B, Kohner EM. Serum immunoreactive insulin responses to a glucose load in Asian Indian and European type 2 (non-insulin-dependent) diabetic patients and control subjects. Diabetologia 1986; 29: 235-237.
12. Sharp PS, Mohan V, Levy JC, Mather HM, Kohner EM. Insulin resistance in patients of Asian Indian and European origin with non-insulin dependent diabetes. Horm Metab Res 1987; 19: 84-85.
13. McKeigue PM, Pierpoint T, Ferrie JE, Marmot MG. Relationship of glucose intolerance and hyperinsulinaemia to body fat pattern in south Asians and Europeans. Diabetologia 1992; 35: 785-791.
14. Simmons D, Powell MJ. Metabolic and clinical characteristics of south Asians and Europeans in Coventry. Diabet Med 1993; 10: 751-758.
15. Misra A, Vikram NK. Insulin resistance syndrome (metabolic syndrome) and Asian Indians. Curr Sci 2002; 83: 1483-1496.
16. Ramachandran A, Snehalatha C, Viswanathan V, Viswanathan M, Haffner SM. Risk of noninsulin dependent diabetes mellitus conferred by obesity and central adiposity in different ethnic groups: a comparative analysis between Asian Indians, Mexican Americans and Whites. Diabet Res Clin Pract 1997; 36: 121-125.
17. Joshi SR. Metabolic syndrome - emerging clusters of the Indian phenotype. J Assoc Phys India 2003; 51: 445-446.
18. Chandalia M, Abate N, Garg A, Stray-Gundersen J, Grundy SM. Relationship between generalized and upper body obesity to insulin resistance in Asian Indian men. J Clin Endocrinol Metab 1999; 84: 2329-2335.
19. Deepa M, Pradeepa R, Rema M, Anjana M, Deepa R, Shanthirani S et al. The Chennai Urban Rural Epidemiology Study (CURES) - study design and methodology (urban component) (CURES - 1). J Assoc Phys India 2003; 51: 863-870.
20. Alberti KG, Zimmet PZ. Definition diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus, provisional report of a WHO consultation. Diabet Med 1998; 15: 539-553.
21. The Asia Pacific perspective: Redefining obesity and its treatment. Regional office for the western Pacific of the World Health Organization. World Health Organization, International association for the study of Obesity and International Obesity Task force. Health Communications Australia Pvt Limited. 22-29 2000.
22. Friedewald WT, Levy RI, Fredrickson DS. Estimation of low density lipoprotein cholesterol without the use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
23. Stefan N, Fritsche A, Machicao F, Tschritter O, Haring HU, Stumvogel M. The Gly1057Asp polymorphism in IRS-2 interacts with obesity to affect beta cell function. Diabetologia 2004; 47: 759-761.
24. D'Alfonso R, Marini MA, Frittita L, Sorge R, Frontoni S, Porzio O et al. Polymorphisms of the IRS-2 in patients with type 2 diabetes. J Clin Endocrinol Metab 2003; 88: 317-322.
25. Okazawa K, Yoshimasa Y, Miyamoto Y, Takahashi-Yasuno A, Miyawaki T, Masuzaki H et al. The haplotypes of the IRS-2 gene affect insulin sensitivity in Japanese patients with type 2 diabetes. Diabet Res Clin Prac 2005; 68: 39-48.
26. Lin X, Taguchi A, Park S, Kushner JA, Li F, Li Yet al. Dysregulation of insulin receptor substrate 2 in β cells and brain causes obesity and diabetes. J Clin Invest 2004; 114: 908-916.
27. Kubota N, Terauchi Y, Tobe K, Yano W, Suzuki R, Ueki K et al. Insulin receptor substrate 2 plays a crucial role in β cells and hypothalamus. J Clin Invest 2004; 114: 917-927.
28. Lautier C, Mkadem SAE, Renard E, Brun JF, Gris JC, Bringer J et al. Complex haplotypes of IRS 2 gene are associated with severe obesity and reveal heterogeneity in the effect of Gly1057Asp mutation. Hum Genet 2003; 113: 34-43.
29. Ehrmann DA, Tang X, Yoshiuchi I, Cox NJ, Bell GI. Relationship of insulin receptor substrate-1 and -2 genotypes to phenotypic features of polycystic ovary syndrome. J Clin Endocrinol Metab 2002; 87: 4297-4300.
30. Comings DE, MacMurray JP. Molecular heterosis: a review. Molec Genet Metab 2000; 71: 19-31.
31. Basu A, Mukherjee N, Roy S, Sengupta S, Banerjee S, Chakraborty M et al. Ethnic India: a genomic view, with special reference to peopling and structure. Genome Res 2003; 13: 2277-2290.
32. Devlin B, Roeder K, Wasserman L. Genomic control, a new approach to genetic-based association studies. Theor Popul Biol 2001; 60: 155-166.